View Single Post
Old 09-24-2009, 08:14 AM   #1
freyja
Senior Member
 
freyja's Avatar
 
Join Date: Sep 2008
Location: Eugene, Oregon
Posts: 347
Lightbulb article on HER2/14-3-3 combo

http://www.cancercompass.com/cancer-...m?c=1004:5:1:2

Overexpressed Protein Converts Noninvasive Breast Cancer Into Invasive Disease

NewsRx.com


[The researchers show that 14-3-3(zeta) teams with the oncoprotein ErbB2, also known as HER2, in a two-hit process to convert normal mammary cells to invasive cancer cells.
In addition to identifying this key step in EMT, Yu notes the findings also provide:



A biomarker in 14-3-3(zeta) to identify high-risk patients for more aggressive treatment before their noninvasive breast cancer converts to invasive disease.


New therapeutic targets among the components of the molecular pathway launched by 14-3-3(zeta). Some drugs already aim at these targets, Yu said.


A solution to a puzzling mystery about how a subset of non-invasive breast cancer with excessive presence of a ErbB2/HER2 develops into invasive breast cancer.]


(more at the link above)
__________________

"Dancers Against Cancer" in the Eugene, OR Komen Race for the Cure 2010
Diagnosed 8/7/08 with stage 3 invasive ductal carcinoma, micropapillary pattern, Her2 3+, ER+,PR-, grade II, positive lymph nodes.
Received 6doses of Taxotere, Carboplatin with Herceptin continuing for a year...DONE.
1/28/09 Left Modified Radical Mastectomy, Right Simple Mastectomy.
Surgery pathology: No invasive carcinoma present and 17 lymph nodes removed all negative! Only small amount of carcinoma in situ in left breast.
March/April '09, Radiation to left chest wall.
Currently involved in Neratinib clinical trial.

"Well being I won
and wisdom too,
I grew and joyed in my growth;
from a word to a word
I was led to a word
from a deed to another deed." (Odin)

freyja is offline   Reply With Quote